// App-Quantinova.ai

OC 10.4 : High throughput Proteomic Profiling in Cancer-Associated VTE and Link to the Clinical Outcome

Researchers

Presenter

  • M. Panova-Noeva

Principal Investigators

  • A. Schulz

  • T. Kck

  • V. ten Cate

  • B. Wagner

  • S. Rapp

  • J. Prochaska

  • M. Sauer

  • A. Zink

  • M. Ghadessi

  • S. Konstantinides

  • H. ten Cate

  • S. Heitmeier

  • P. Wild

Medical Centers

  • Clinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany

  • DZHK (German Center for Cardiovascular Research), Partner Site RhineMain, Mainz, Germany

  • Preventive Cardiology and Preventive Medicine, Dept of Cardiology, Univ Med Cntr of the Johannes Gutenberg Univ Mainz, Germany

  • Bayer Pharma AG, Berlin, Germany

  • Clinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany

  • Laboratory for Clinical Thrombosis and Haemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, Netherlands

Locations

  • Germany

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A